This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/735    most recent 01.HYP.0000036452.28493.74v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cervenka, L. Articles by Navar, L. G. Search for Related Content PubMed PubMed Citation Articles by Cervenka, L. Articles by Navar, L. G. Related Collections Hypertension - basic studies

(Hypertension. 2002;40:735.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Essential Role of AT_1A Receptor in the Development of 2K1C Hypertension

Ludk ervenka; Vladislav Horáek; Ivana Vanková; Jaroslav A. Hubáek; Michael I. Oliverio; Thomas M. Coffman; L. Gabriel Navar

From the Center for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine (L..), V.H., I.V., J.A.H.), Prague, Czech Republic; Department of Medicine, Duke University, Winston-Salem, and Durham Veterans Affairs Medical Center (M.I.O., T.M.C.), Durham, NC; Department of Physiology, Tulane University School of Medicine (L.G.N.), New Orleans, La; and Department of Physiology, Second Medical Faculty, Charles University (L..), Prague, Czech Republic.

Correspondence to Ludk ervenka, MD, PhD, Center for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, 1958/9 Videská, CZ-140 21 Prague 4, Czech Republic. E-mail luce{at}medicon.cz

The aims of this study were to delineate the relative contribution of angiotensin II (ANG II) subtype 1A (AT_1A) and 1B (AT_1B) receptors to the development of two-kidney, one-clip (2K1C) Goldblatt hypertension in mice, to examine if increased nitric oxide synthase (NOS) activity counteracts the vasoconstrictor influences of ANG II in 2K1C hypertensive mice, and to determine the role of ANG II type 2 (AT₂) receptors in 2K1C hypertension in mice. AT_1A ANG II receptor knockout (AT_1A-/-) and wild-type (AT_1A+/+) mice underwent clipping of the right renal artery. Systolic blood pressure (SBP) was significantly lower in AT_1A-/- compared with AT_1A+/+ mice, and neither clip placement nor AT₂ receptor blockade with PD 123319 (PD) altered SBP in AT_1A-/- mice. A significant and sustained rise in SBP from 119±5 to 163±6 mm Hg was observed in the 2K1C AT_1A+/+ mice from day 10 to day 26. Chronic PD infusion did not alter the course of hypertension in 2K1C/AT_1A+/+. Acute PD infusion did not alter mean arterial pressure (MAP) in AT_1A+/+, PD/AT_1A+/+, 2K1C/AT_1A+/+, PD/2K1C/AT_1A+/+, AT_1A-/-, PD/AT_1A-/-, and PD/2K1C/AT_1A-/- mice compared with basal levels. In contrast, acute PD infusion caused significant increases in MAP in 2K1C/AT_1A-/- mice. The subsequent acute NOS inhibition caused greater increases in MAP in 2K1C/AT_1A+/+ and PD/2K1C/AT_1A+/+ mice than in AT_1A+/+ and PD/AT_1A+/+ mice. These results support the essential role of AT_1A receptors in mediating 2K1C hypertension and support the hypothesis that augmented NO production serves as a counteracting system in this model of hypertension.

Key Words: mice • receptors, angiotensin II • hypertension, renovascular • nitric oxide synthase • nitric oxide

This article has been cited by other articles:

				R. A. Gonzalez-Villalobos, D. M. Seth, R. Satou, H. Horton, N. Ohashi, K. Miyata, A. Katsurada, D. V. Tran, H. Kobori, and L. G. Navar Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice Am J Physiol Renal Physiol, September 1, 2008; 295(3): F772 - F779. [Abstract] [Full Text] [PDF]

				P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease Hypertension, May 1, 2008; 51(5): 1379 - 1385. [Abstract] [Full Text] [PDF]

				J. Stegbauer, Y. Kuczka, O. Vonend, I. Quack, L. Sellin, A. Patzak, A. Steege, K. Langnaese, and L. C. Rump Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R421 - R428. [Abstract] [Full Text] [PDF]

				X. C. Li and J. L. Zhuo In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice Am J Physiol Renal Physiol, February 1, 2008; 294(2): F293 - F302. [Abstract] [Full Text] [PDF]

				J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis Hypertension, February 1, 2008; 51(2): 466 - 473. [Abstract] [Full Text] [PDF]

				D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3072 - H3079. [Abstract] [Full Text] [PDF]

				L. M. Bivol, R. K. Berge, and B. M. Iversen Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845. [Abstract] [Full Text] [PDF]

				J. E. Wagenseil, R. H. Knutsen, D. Y. Li, and R. P. Mecham Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H574 - H582. [Abstract] [Full Text] [PDF]

				A. M. Nuyt and M. Szyf Developmental Programming Through Epigenetic Changes Circ. Res., March 2, 2007; 100(4): 452 - 455. [Full Text] [PDF]

				F. Helle, O. B. Vagnes, and B. M. Iversen Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147. [Abstract] [Full Text] [PDF]

				R. M.P. Arruda, V. A. Peotta, S. S. Meyrelles, and E. C. Vasquez Evaluation of Vascular Function in Apolipoprotein E Knockout Mice With Angiotensin-Dependent Renovascular Hypertension Hypertension, October 1, 2005; 46(4): 932 - 936. [Abstract] [Full Text] [PDF]

				V. D. Garovic and S. C. Textor Renovascular Hypertension and Ischemic Nephropathy Circulation, August 30, 2005; 112(9): 1362 - 1374. [Full Text] [PDF]

				L. M. Bivol, O. B. Vagnes, and B. M. Iversen The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400. [Abstract] [Full Text] [PDF]

				H. Hiyoshi, K. Yayama, M. Takano, and H. Okamoto Angiotensin Type 2 Receptor-Mediated Phosphorylation of eNOS in the Aortas of Mice With 2-Kidney, 1-Clip Hypertension Hypertension, May 1, 2005; 45(5): 967 - 973. [Abstract] [Full Text] [PDF]

				Z. Sun, X. Wang, C. E. Wood, and J. R. Cade Genetic AT1A receptor deficiency attenuates cold-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R433 - R439. [Abstract] [Full Text] [PDF]

				M. P. Printz The Confluence of Population Genetics with Molecular Pharmacology at the Angiotensin II Receptor: Dawn of a New Era or Just a New Wrinkle? Mol. Pharmacol., March 1, 2004; 65(3): 488 - 491. [Full Text] [PDF]